 Connection
Lisa Bero to Australia
This is a "connection" page, showing publications Lisa Bero has written about Australia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.838 |
|
|
|
-
Chiu K, Thow AM, Bero L. Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia. Int J Health Policy Manag. 2023; 12:6872.
Score: 0.193
-
Grundy Q, Huyer LD, Parker L, Bero L. Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines. Policy Polit Nurs Pract. 2023 Feb; 24(1):67-75.
Score: 0.189
-
Karanges EA, Nangla C, Parker L, Fabbri A, Farquhar C, Bero L. Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. BMJ Open. 2021 08 31; 11(9):e049710.
Score: 0.177
-
Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open. 2021 02 09; 11(2):e045140.
Score: 0.170
-
Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. "There are ways ? drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. Br J Clin Pharmacol. 2021 05; 87(5):2341-2353.
Score: 0.167
-
Chartres N, Grundy Q, Parker LM, Bero LA. "It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. Int J Health Policy Manag. 2020 08 01; 9(8):335-343.
Score: 0.164
-
Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ Open. 2020 05 10; 10(5):e034195.
Score: 0.161
-
Karanges EA, Ting N, Parker L, Fabbri A, Bero L. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Aust J Gen Pract. 2020 03; 49(3):151-154.
Score: 0.159
-
Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ. 2019 12 12; 367:l6694.
Score: 0.157
-
Behdarvand B, Karanges EA, Bero L. Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study. BMJ Open. 2019 08 20; 9(8):e030253.
Score: 0.153
-
Parker L, Karanges EA, Bero L. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. BMJ Open. 2019 02 19; 9(2):e024928.
Score: 0.148
-
Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ Open. 2019 02 05; 9(2):e025864.
Score: 0.148
-
Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open. 2018 02 13; 8(2):e019027.
Score: 0.138
-
Grundy Q, Held F, Bero L. A Social Network Analysis of the Financial Links Backing Health and Fitness Apps. Am J Public Health. 2017 11; 107(11):1783-1788.
Score: 0.134
-
Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open. 2017 06 30; 7(6):e016701.
Score: 0.132
-
Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner? JAMA Intern Med. 2016 11 01; 176(11):1718-1720.
Score: 0.126
-
Pokorny AMJ, Bero LA, Fox P, Karikios DJ, McEwin EJ, Moynihan R, Mintzes B. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 2023 05 26; 13(5):e065719.
Score: 0.050
-
Pokorny AMJ, Moynihan R, Fox P, Karikios DJ, Bero LA, Mintzes BJ. Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions. JCO Oncol Pract. 2022 07; 18(7):e1154-e1163.
Score: 0.046
-
Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures. Intern Med J. 2021 Nov; 51(11):1816-1824.
Score: 0.045
-
Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021 02; 30(2):133-140.
Score: 0.040
-
Parker L, Bero L, Gillies D, Raven M, Grundy Q. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena. Int J Health Policy Manag. 2019 03 01; 8(3):168-176.
Score: 0.037
-
Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q. Mental Health Messages in Prominent Mental Health Apps. Ann Fam Med. 2018 07; 16(4):338-342.
Score: 0.035
-
Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public Opinions about Overdiagnosis: A National Community Survey. PLoS One. 2015; 10(5):e0125165.
Score: 0.029
-
Robertson J, Walkom E, Moynihan R, Bero L, Henry D. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract. 2010 Apr; 18(2):88-92.
Score: 0.020
-
Robertson J, Moynihan R, Walkom E, Bero L, Henry D. Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med. 2009 Nov; 6(11):e1000128.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|